126 related articles for article (PubMed ID: 16525649)
1. Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells.
Murad H; Collet P; Huin-Schohn C; Al-Makdissy N; Kerjan G; Chedotal A; Donner M; Devignes MD; Becuwe P; Schohn H; Domenjoud L; Dauça M
Int J Oncol; 2006 Apr; 28(4):977-84. PubMed ID: 16525649
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes.
Nagase I; Yoshida S; Canas X; Irie Y; Kimura K; Yoshida T; Saito M
FEBS Lett; 1999 Nov; 461(3):319-22. PubMed ID: 10567719
[TBL] [Abstract][Full Text] [Related]
3. Regulation of aromatase by nuclear receptors.
Yanase T; Mu YM; Nishi Y; Goto K; Nomura M; Okabe T; Takayanagi R; Nawata H
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):187-92. PubMed ID: 11850224
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
[TBL] [Abstract][Full Text] [Related]
5. Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS
Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.
Kim HI; Kim JW; Kim SH; Cha JY; Kim KS; Ahn YH
Diabetes; 2000 Sep; 49(9):1517-24. PubMed ID: 10969836
[TBL] [Abstract][Full Text] [Related]
7. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
Toyota M; Miyazaki Y; Kitamura S; Nagasawa Y; Kiyohara T; Shinomura Y; Matsuzawa Y
Life Sci; 2002 Feb; 70(13):1565-75. PubMed ID: 11895107
[TBL] [Abstract][Full Text] [Related]
9. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells.
Bonofiglio D; Cione E; Qi H; Pingitore A; Perri M; Catalano S; Vizza D; Panno ML; Genchi G; Fuqua SA; Andò S
Am J Pathol; 2009 Sep; 175(3):1270-80. PubMed ID: 19644018
[TBL] [Abstract][Full Text] [Related]
10. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
Aoun P; Watson DG; Simpkins JW
Eur J Pharmacol; 2003 Jul; 472(1-2):65-71. PubMed ID: 12860474
[TBL] [Abstract][Full Text] [Related]
13. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
14. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
15. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J
EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
Mu YM; Yanase T; Nishi Y; Waseda N; Oda T; Tanaka A; Takayanagi R; Nawata H
Biochem Biophys Res Commun; 2000 May; 271(3):710-3. PubMed ID: 10814527
[TBL] [Abstract][Full Text] [Related]
18. Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation.
Monden T; Yamada M; Nihei Y; Kishi M; Tomaru T; Ishii S; Hashida T; Shibusawa N; Hashimoto K; Satoh T; Kasai K; Mori M
Life Sci; 2004 Dec; 76(7):731-41. PubMed ID: 15581905
[TBL] [Abstract][Full Text] [Related]
19. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
Pandhare J; Cooper SK; Phang JM
J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]